Key statistics
On Friday, Legend Biotech Corp (LEGN:NSQ) closed at 49.07, 27.12% above the 52 week low of 38.60 set on Jun 03, 2024.
52-week range
Open | 48.92 |
---|---|
High | 50.83 |
Low | 48.30 |
Bid | 48.93 |
Offer | 49.50 |
Previous close | 47.79 |
Average volume | 1.15m |
---|---|
Shares outstanding | 184.29m |
Free float | 181.21m |
P/E (TTM) | -- |
Market cap | 9.04bn USD |
EPS (TTM) | -1.57 USD |
Data delayed at least 15 minutes, as of Oct 04 2024 21:00 BST.
More ▼
- Legend Biotech to Establish New, State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
- CARVYKTI® is the First and Only Cell Therapy to Significantly Extend Overall Survival Compared to Standard of Care in Patients with Multiple Myeloma as Early as Second Line
- Legend Biotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
- Legend Biotech Reports Second Quarter 2024 Results and Recent Highlights
- Legend Biotech Appoints Peter Salovey, Ph.D., to its Board of Directors
- Legend Biotech Announces Preliminary Results for the Six-Months Ended June 30, 2024
- Legend Biotech to Host Investor Conference Call on Second Quarter 2024 Results
- Legend Biotech Announces Positive Overall Survival Results of Landmark Phase 3 CARTITUDE-4 Trial in Multiple Myeloma
More ▼